Tag Archives: Pfizer

The Associated Press reports: The U.S. government is close to a deal to acquire tens of millions of additional doses of Pfizer’s vaccine in exchange for helping the pharmaceutical giant gain better access to manufacturing supplies. A person with knowledge of the negotiations told The Associated Press on Tuesday that the deal is under discussion and could be finalized shortly. …

The Los Angeles Times reports: The COVID-19 vaccine is here — and so are the wealthy people who want it first. “We get hundreds of calls every single day,” said Dr. Ehsan Ali, who runs Beverly Hills Concierge Doctor. His clients, who include Ariana Grande and Justin Bieber, pay between $2,000 and $10,000 a year for personalized care. “This is …

Politico reports: The nation’s system for distributing coronavirus vaccines lacks safeguards to ensure the next wave of doses reaches the most critical workers and at-risk patients rather than star athletes or the well-connected. There’s little chance for anyone to jump the line right now while an extremely limited supply of the vaccine is being distributed. But as soon as more …

Via press release from Pfizer: Pfizer Inc. today released the following statement to address public comments that allege there are issues in the production and distribution of the company’s COVID-19 vaccine: Pfizer is not having any production issues with our COVID-19 vaccine, and no shipments containing the vaccine are on hold or delayed. This week, we successfully shipped all 2.9 …

The Washington Post reports: The Food and Drug Administration said Wednesday that pharmacists can draw additional doses from vials of the Pfizer coronavirus vaccine, potentially expanding the country’s supply by millions of doses as the Trump administration negotiates with Pfizer to speed up the next round of vaccine deliveries. The government’s existing supply of the first authorized vaccine can be …

ABC News reports: With the trucks rolling and the first government-authorized coronavirus vaccine making its way to all 50 states, a strong majority of Americans are inclined to get the vaccine but are divided over exactly when, a new ABC News/Ipsos poll released Monday finds. More than eight in 10 Americans say they would receive the vaccine, with 40% saying …

The Associated Press reports: The first of many freezer-packed COVID-19 vaccine vials made their way to distribution sites across the United States on Sunday, as the nation’s pandemic deaths approached the horrifying new milestone of 300,000. “This is a historic day,” said Richard W. Smith, who oversees operations in the Americas for FedEx Express, which is delivering 630-some packages of …

CNN reports: Freight trucks carrying about 184,275 vials of coronavirus vaccine departed a Pfizer plant in Portage, Michigan, on Sunday, a landmark moment in the fight against the deadly virus. The combined 189 boxes of vaccine vials are expected to arrive in all 50 states on Monday, and another 3,900 vials are expected to ship later Sunday to United States …

The New York Times reports: The Food and Drug Administration’s emergency authorization on Friday night of the vaccine developed by Pfizer and BioNTech has set in motion the most ambitious vaccination campaign in the nation’s history, a challenge of staggering proportions choreographed against a backdrop of soaring infection rates and deaths. This weekend, 2.9 million doses of the vaccine are …

CNBC reports: The Food and Drug Administration has approved Pfizer and BioNTech’s coronavirus vaccine for emergency use, a monumental turning point in the once-in-a-century pandemic that has taken nearly 300,000 American lives in less than a year and wreaked havoc on the U.S. economy. FDA Chief Scientist Denise Hinton told Pfizer in a letter Friday that she was authorizing the …

Forbes reports: Members of FDA’s Vaccine and Related Biological Products Advisory Committee endorsed Pfizer and BioNTech’s Covid-19 vaccine candidate on Thursday, clearing the last hurdle before emergency use authorization from the federal agency. The committee, also called VRBPAC, met for nine hours to discuss all aspects of the new Covid-19 vaccine, from risk and safety to how Pfizer and BioNTech …

The Hill reports: The U.S. Food and Drug Administration’s vaccines and related biological products advisory committee on Thursday morning is set to discuss Pfizer’s request for emergency use authorization of its COVID-19 vaccine. The hearing is scheduled to begin at 9AM Eastern. CNBC reports: The non-binding decision from the agency’s Vaccines and Related Biological Products Advisory Committee, an outside group …

The Wall Street Journal reports: Pfizer Inc. and BioNTech SE, racing ahead of the U.S. Food and Drug Administration and Europe’s main regulator to approve shots for its most vulnerable citizens. Canada will now begin its immunization rollout as early as next week—a daunting challenge for a country that is the second-largest in the world in terms of land mass …

The Hill reports: Former Food and Drug Administration Commissioner Scott Gottlieb [photo], now a member of the Pfizer board of directors, said Tuesday that the pharmaceutical giant offered the Trump administration the chance to buy additional doses of its coronavirus vaccine multiple times, but that officials turned down the offers. The comments from Gottlieb confirm a report in The New …

The New York Times reports: The coronavirus vaccine made by Pfizer and BioNTech provides strong protection against Covid-19 within about 10 days of the first dose, according to documents published on Tuesday by the Food and Drug Administration before a meeting of its vaccine advisory group. The finding is one of several significant new results featured in the briefing materials, …

CNBC reports: The U.K. is rolling out the first coronavirus vaccines to the public on Tuesday, making it one of the first countries in the world to do so. Member of the public Margaret Keenan, a 90 year-old grandmother, made history as she became the first person in the world to receive the Pfizer-BioNTech vaccine outside of trial conditions. The …

STAT News reports: Both Pfizer and Moderna, the two major drug manufacturers likely to receive emergency authorizations for a Covid-19 vaccine in the coming weeks, have rejected invitations from President Trump to appear at a White House “Vaccine Summit” on Tuesday, according to two sources familiar with the event’s planning. The Trump administration has openly feuded with Pfizer in recent …

Salon reports: Sen. David Perdue, one of two multimillionaire Georgia Republicans facing tight runoff elections in January, drew scrutiny this spring for stock transactions made in the weeks ahead of the coronavirus outbreak in the U.S., while he was receiving privileged briefings on the impending pandemic. In a series of transactions in late February, Perdue also invested up to $245,000 …

The BBC reports: The UK has become the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine, paving the way for mass vaccination. Britain’s medicines regulator, the MHRA, says the jab, which offers up to 95% protection against Covid-19 illness, is safe to be rolled out. The first 800,000 doses will be available in the UK from next …

The New York Times reports: Around mid-December, 6.4 million doses of Pfizer’s Covid-19 vaccine will be shipped out across the United States in an initial push after it receives an expected emergency authorization, officials leading Operation Warp Speed, the administration’s push to fast-track a vaccine, said on a call with reporters on Tuesday. The first doses — which are expected …